December 16th, 2016
•The protocol described here details the induction of a hemogenic program in mouse embryonic fibroblasts via overexpression of a minimal set of transcription factors. This technology may be translated to the human system to provide platforms for future study of hematopoiesis, hematologic disease, and hematopoietic stem cell transplant.
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved